Lack of Accredited Clinical Training in Movement Disorders in Europe, Egypt, and Tunisia.


Journal

Journal of Parkinson's disease
ISSN: 1877-718X
Titre abrégé: J Parkinsons Dis
Pays: Netherlands
ID NLM: 101567362

Informations de publication

Date de publication:
2020
Historique:
pubmed: 12 7 2020
medline: 18 9 2021
entrez: 12 7 2020
Statut: ppublish

Résumé

Little information is available on the official postgraduate and subspecialty training programs in movement disorders (MD) in Europe and North Africa. To survey the accessible MD clinical training in these regions. We designed a survey on clinical training in MD in different medical fields, at postgraduate and specialized levels. We assessed the characteristics of the participants and the facilities for MD care in their respective countries. We examined whether there are structured, or even accredited postgraduate, or subspecialty MD training programs in neurology, neurosurgery, internal medicine, geriatrics, neuroradiology, neuropediatrics, and general practice. Participants also shared their suggestions and needs. The survey was completed in 31/49 countries. Structured postgraduate MD programs in neurology exist in 20 countries; structured neurology subspecialty training exists in 14 countries and is being developed in two additional countries. Certified neurology subspecialty training was reported to exist in 7 countries. Recommended reading lists, printed books, and other materials are the most popular educational tools, while courses, lectures, webinars, and case presentations are the most popular learning formats. Mandatory activities and skills to be certified were not defined in 15/31 countries. Most participants expressed their need for a mandatory postgraduate MD program and for certified MD sub-specialization programs in neurology. Certified postgraduate and subspecialty training exists only in a minority of European countries and was not found in the surveyed Egypt and Tunisia. MD training should be improved in many countries.

Sections du résumé

BACKGROUND
Little information is available on the official postgraduate and subspecialty training programs in movement disorders (MD) in Europe and North Africa.
OBJECTIVE
To survey the accessible MD clinical training in these regions.
METHODS
We designed a survey on clinical training in MD in different medical fields, at postgraduate and specialized levels. We assessed the characteristics of the participants and the facilities for MD care in their respective countries. We examined whether there are structured, or even accredited postgraduate, or subspecialty MD training programs in neurology, neurosurgery, internal medicine, geriatrics, neuroradiology, neuropediatrics, and general practice. Participants also shared their suggestions and needs.
RESULTS
The survey was completed in 31/49 countries. Structured postgraduate MD programs in neurology exist in 20 countries; structured neurology subspecialty training exists in 14 countries and is being developed in two additional countries. Certified neurology subspecialty training was reported to exist in 7 countries. Recommended reading lists, printed books, and other materials are the most popular educational tools, while courses, lectures, webinars, and case presentations are the most popular learning formats. Mandatory activities and skills to be certified were not defined in 15/31 countries. Most participants expressed their need for a mandatory postgraduate MD program and for certified MD sub-specialization programs in neurology.
CONCLUSION
Certified postgraduate and subspecialty training exists only in a minority of European countries and was not found in the surveyed Egypt and Tunisia. MD training should be improved in many countries.

Identifiants

pubmed: 32651331
pii: JPD202000
doi: 10.3233/JPD-202000
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1833-1843

Auteurs

Gertrúd Tamás (G)

Department of Neurology, Semmelweis University, Budapest, Hungary.

Margherita Fabbri (M)

Department of Neuroscience "Rita Levi Montalcini", University of Turin, Italy.
Instituto de Medicina Molecular, Lisbon, Portugal.
Laboratory of Clinical Pharmacology and Therapeutics, Faculdade de Medicina, Universidade de Lisboa, Portugal.

Cristian Falup-Pecurariu (C)

Department of Neurology, Transilvania University, Braşov, Romania.

Tiago Teodoro (T)

Instituto de Medicina Molecular, Lisbon, Portugal.
Neurosciences Research Centre, Molecular and Clinical Sciences Research Institute, St George's, University of London, London, UK.
Ashford and St Peter's Hospital NHS Trust, Chertsey, Surrey, UK.

Mónica M Kurtis (MM)

Movement Disorders Unit, Neurology Department, Hospital Ruber Internacional, Madrid, Spain.

Rahim Aliyev (R)

Department of Neurology and Clinical Neurophysiology, Azerbaijan State Advanced Training Institute for Doctors named after A. Aliyev, Baku, Republic of Azerbaijan.

Michael Bonello (M)

Department of Neurology, The Walton Centre NHS Foundation Trust, Liverpool, UK.

Hana Brozova (H)

Department of Neurology and Center of Clinical Neuroscience, Charles University, First Faculty of Medicine, Prague, Czech Republic.

Miguel Soares Coelho (MS)

Instituto de Medicina Molecular, Lisbon, Portugal.
Laboratory of Clinical Pharmacology and Therapeutics, Faculdade de Medicina, Universidade de Lisboa, Portugal.
Department of Neurosciences, Neurology Service, Hospital Santa Maria, Lisbon, Portugal.

Maria Fiorella Contarino (MF)

Department of Neurology, Leiden University Medical Center, Leiden, The Netherlands.
Department of Neurology, Haga Teaching Hospital, The Hague, The Netherlands.

Jean-Christophe Corvol (JC)

Department of Neurology, Sorbonne Université, Assistance Publique Hôpitaux de Paris, Inserm, CNRS, Hôpital Pitié-Salpêtrière, Institut du Cerveau et de la Moelle, Paris, France.

Espen Dietrichs (E)

Department of Neurology, Oslo University Hospital and University of Oslo, Oslo, Norway.

Mouna Ben Djebara (M)

Department of Neurology, Razi Hospital, Faculté de Médecine de Tunis, University Tunis-El Manar, Tunisia.

Søren Bruno Elmgreen (SB)

Department of Neurology, Aalborg University Hospital, Aalborg, Denmark.

Sergiu Groppa (S)

Department of Neurology, Movement Disorders, Imaging and Neurostimulation, University Medical Center of the Johannes Gutenberg University, Mainz, Germany.

Liis Kadastik-Eerme (L)

Department of Neurology and Neurosurgery, University of Tartu, Tartu, Estonia.
Department of Neurology, Tartu University Hospital, Tartu, Estonia.

Irine Khatiashvili (I)

Department of Clinical Neurology, Tbilisi State Medical University, Tbilisi, Georgia.

Vladimir Kostić (V)

Department of Neurology CCS, University of Belgrade, Belgrade, Serbia.

Florian Krismer (F)

Department of Neurology, Medical University Innsbruck, Innsbruck, Austria.

Alia Hassan Mansour (A)

Department of Neurology, Faculty of Medicine, Ain Shams University, Cairo, Egypt.

Per Odin (P)

Department of Clinical Sciences, Division of Neurology, Lund University, Lund, Sweden.

Olga Gavriliuc (O)

Department of Neurology, State University of Medicine and Pharmacy Nicolae Testemitanu, Chisinau, Republic of Moldova.

Diana Angelika Olszewska (DA)

Department of Neurology, Dublin Neurological Institute at the Mater Misericordiae University Hospital, Dublin, Ireland.

Maja Relja (M)

Croatian Academy of Medical Sciences and School of Medicine, Zagreb University, Zagreb, Croatia.

Filip Scheperjans (F)

Department of Neurology, Helsinki University Hospital, and Department of Neurological Sciences (Neurology), University of Helsinki, Helsinki, Finland.

Matej Skorvanek (M)

Department of Neurology, Faculty of Medicine, P. J. Safarik University, Kosice, Slovak Republic.
Department of Neurology, University Hospital L. Pasteur, Kosice, Slovak Republic.

Katarzyna Smilowska (K)

Silesian Center of Neurology, Katowice, Poland.

Pille Taba (P)

Department of Neurology and Neurosurgery, University of Tartu, Tartu, Estonia.
Department of Neurology, Tartu University Hospital, Tartu, Estonia.

Zaruhi Tavadyan (Z)

Department of Neurology and Neurosurgery, National Institute of Health, Yerevan, Armenia.
"Somnus" Sleep and Movement Disorders Clinic, Yerevan, Armenia.

Ramona Valante (R)

Department of Neurology, Pauls Stradiņš Clinical University Hospital, Riga, Latvia.

Balsa Vujovic (B)

Department of Neurology, Clinical Center of Montenegro, Podgorica, Montenegro.

Daniel Waldvogel (D)

Department of Neurology, University Hospital Zurich, Zurich, Switzerland.

Gul Yalcin-Cakmakli (G)

Department of Neurology, Hacettepe University, Ankara, Turkey.

Shilpa Chitnis (S)

Department of Neurology and Neurotherapeutics, Southwestern Medical Center, University of Texas, Dallas, Texas, US.

Joaquim J Ferreira (JJ)

Instituto de Medicina Molecular, Lisbon, Portugal.
Laboratory of Clinical Pharmacology and Therapeutics, Faculdade de Medicina, Universidade de Lisboa, Portugal.
CNS - Campus Neurológico Sénior, Torres Vedras, Portugal.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH